Acolbifene in Preventing Cancer in Premenopausal Women at High Risk of Breast Cancer

NCT00853996 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: acolbifene hydrochloride

Sponsor

University of Kansas Medical Center

Collaborators

[object Object]